针对神经退行性疾病和脑瘤的基于mRNA的治疗方法的最新进展
Lizhi Yang1, Shuo Li1, Chao Hou2
1Department of Ultrasound, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. hewenbjtt@163.com.
Nanoscale
|January 3, 2025
概括
使者RNA (mRNA) 疗法通过指导蛋白质合成提供了一种精确和安全的新方法来治疗疾病. 这种创新疗法在治疗神经退行性疾病和脑瘤方面表现有前途,克服了诸如血脑屏障等挑战.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 治疗方法 治疗方法
背景情况:
- 使者RNA (mRNA) 疗法为治疗性蛋白质合成提供蛋白质编码信息.
- 与基因疗法不同,mRNA不会进入细胞核,从而降低了整合风险.
- mRNA疗法在精度,安全性和修改灵活性方面具有优势.
研究的目的:
- 审查mRNA疗法的制备和输送.
- 总结使用mRNA基因疗法治疗神经退行性疾病 (NDs) 和脑瘤的研究进展.
- 讨论当前的挑战,并为未来的研究提供参考.
主要方法:
- 审查关于mRNA药物制备和输送的现有文献.
- 分析针对ND和脑瘤的mRNA治疗研究进展情况.
- 讨论mRNA治疗开发中的挑战.
主要成果:
- mRNA疗法是一种下一代策略,在疾病治疗中具有应用,包括COVID-19预防.
- 神经退行性疾病和脑瘤是mRNA治疗的合适点,因为它们的进展缓慢,以及像血脑屏障这样的挑战.
- 预计持续的研究将扩大mRNA疗法在治疗这些疾病中的作用.
结论:
- mRNA疗法为神经退行性疾病和脑瘤提供了一个有前途的治疗策略.
- 克服交付和配方方面的挑战将是实现mRNA疗法的全部潜力的关键.
- 进一步的研究将建立基于mRNA的治疗方法,作为神经瘤学和神经学中的重要工具.
相关概念视频
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Regulated mRNA Transport
6.2K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
6.2K
RNA Editing
8.9K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.9K


